John H. Markels's most recent trade in Sangamo Therapeutics Inc was a trade of 50,000 Stock Option (Right to Buy) done . Disclosure was reported to the exchange on June 12, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Sangamo Therapeutics Inc | John H. Markels | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Jun 2025 | 50,000 | 50,000 | - | - | Stock Option (Right to Buy) | |
| Sangamo Therapeutics Inc | John H. Markels | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Jun 2025 | 25,000 | 96,384 (0%) | 0% | 0 | Common Stock | |
| Arcturus Therapeutics Hold... | John H. Markels | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Jun 2025 | 15,000 | 15,000 | - | - | Stock option (right to buy) | |
| Arcturus Therapeutics Hold... | John H. Markels | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Jun 2024 | 15,000 | 15,000 | - | - | Stock option (right to buy) | |
| Arcturus Therapeutics Hold... | John H. Markels | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 14 Jun 2024 | 3,131 | 3,131 (0%) | 0% | 0 | Common Stock | |
| Arcturus Therapeutics Hold... | John H. Markels | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 14 Jun 2024 | 3,131 | 0 | - | - | Deferred Stock Units | |
| Sangamo Therapeutics Inc | John H. Markels | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Jun 2024 | 50,000 | 50,000 | - | - | Stock Option (Right to Buy) | |
| Sangamo Therapeutics Inc | John H. Markels | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Jun 2024 | 25,000 | 71,384 (0%) | 0% | 0 | Common Stock | |
| Arcturus Therapeutics Hold... | John H. Markels | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Aug 2023 | 11,869 | 11,869 | - | - | Stock option (right to buy) | |
| Arcturus Therapeutics Hold... | John H. Markels | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Aug 2023 | 3,131 | 3,131 | - | - | Deferred Stock Units | |
| Sangamo Therapeutics Inc | John H. Markels | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Jun 2023 | 27,750 | 27,750 | - | - | Stock Option (Right to Buy) | |
| Sangamo Therapeutics Inc | John H. Markels | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Jun 2023 | 13,900 | 46,384 (0%) | 0% | 0 | Common Stock | |
| Arcturus Therapeutics Hold... | John H. Markels | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Dec 2022 | 20,000 | 20,000 | - | - | Stock option (right to buy) | |
| Arcturus Therapeutics Hold... | John H. Markels | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Dec 2022 | 6,986 | 6,986 | - | - | Stock option (right to buy) | |
| Sangamo Therapeutics Inc | John H. Markels | Director | Purchase of securities on an exchange or from another person at price $ 3.69 per share. | 03 Jun 2022 | 6,784 | 32,484 (0%) | 0% | 3.7 | 25,029 | Common Stock |
| Sangamo Therapeutics Inc | John H. Markels | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 Feb 2022 | 25,000 | 25,000 | - | - | Stock Option (Right to Buy) | |
| Sangamo Therapeutics Inc | John H. Markels | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 Feb 2022 | 12,500 | 25,700 (0%) | 0% | 0 | Common Stock | |
| Sangamo Therapeutics Inc | John H. Markels | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 Feb 2021 | 16,400 | 16,400 | - | - | Stock Option (Right to Buy) | |
| Sangamo Therapeutics Inc | John H. Markels | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 Feb 2021 | 8,200 | 13,200 (0%) | 0% | 0 | Common Stock |